Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Open accessThe DOI matches its Crossref record; 273 of the 274 references it cites were found in a registry or an index.
Abstract
Studies of psychiatric disorders have traditionally focused on emotional symptoms such as depression, anxiety and hallucinations. However, poorly controlled cognitive deficits are equally prominent and severely compromise quality of life, including social and professional integration. Consequently, intensive efforts are being made to characterize the cellular and cerebral circuits underpinning cognitive function, define the nature and causes of cognitive impairment in psychiatric disorders and identify more effective treatments. Successful development will depend on rigorous validation in animal models as well as in patients, including measures of real-world cognitive functioning. This article critically discusses these issues, highlighting the challenges and opportunities for improving cognition in individuals suffering from psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because memory impairments were observed in MDD patients (Dere et al. 2010; Millan et al. 2012), the recovery of memory deficits in animal models of AD after administration of DHF could be expected.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Millan et al. 2012
In the citing paper
“Executive dysfunction (ED) is a transdiagnostic factor in various psychopathologies (13,14)”
From Impact of Childhood Trauma on Executive Function in Adolescence—Mediating Functional Brain Networks and Prediction of High-Risk Drinking (2020) · cites this paper as [13]
In the citing paper
“Pair-bond formation is a social cognitive process that involves both social recognition and social reward (27–29) and models a human attachment relationship far more closely than do the social interactions of adult mice or rats.”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [27]
In the citing paper
“The prairie vole (Microtus ochrogaster), a socially monogamous rodent native to the American Midwest (24), is the premier animal model for the neurobiology of social bonding (25) and increasingly used to screen drugs that have therapeutic potential for social disorders such as autism (26,27).”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [27]
In the citing paper
“The pathways whereby this effect occurs are opaque; changes in appetite and energy balance may have negative effects on cognition because interference in the metabolism of glucose may lead to insulin resistance [84], abnormal neurotransmitter turnover, mitochondrial dysfunction, and energy deficits, as well as changes in neural plasticity [85].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [85]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Complex brain networks: graph theoretical analysis of structural and functional systems
Bullmore, E., & Sporns, O. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2575 · Cited by 11,820 · cited 1×
“Networks that modulate cognition display considerable redundancy and pleiotropy at all levels of integration: from intracellular signals, to neurons, to cerebral nucle”
BackgroundSelf-citationParallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Effects of stress throughout the lifespan on the brain, behaviour and cognition
Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2639 · Cited by 6,256
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Cattaneo, L., & Rizzolatti, G. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.41 · Cited by 3,137
On the relationship between emotion and cognition
Pessoa, L. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2317 · Cited by 2,350 · cited 16×
“Specificity relative to generalized changes in overall intelligence remains under discussion, in 1Institut de Recherche Servier, 78290 Croissy/Seine, France.”
InfluentialNew neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
Deng, W., Aimone, J. B., & Gage, F. H. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2822 · Cited by 2,120 · cited 1×
“This is perhaps not surprising, as both deficient and excessive LTP, LTD, 'plasticity gene' activity, neurogenesis and dendritic spine generation have a deleterious effect on cognitive processin”
BackgroundNeurophysiological and Computational Principles of Cortical Rhythms in Cognition
Wang, X.-J. (2010) · Physiological Reviews · doi:10.1152/physrev.00035.2008 · Cited by 1,939 · cited 1×
“Finally, representing a level of integration that is intermediate between cells and cerebral circuits, neurons do not generally act in isolation; rather, they operate as synchronized and rhythmically active assemblies to encode, transmit and modulate information underpinning cognitive functio”
BackgroundThe Social Brain: Neural Basis of Social Knowledge
Adolphs, R. (2009) · Annual Review of Psychology · doi:10.1146/annurev.psych.60.110707.163514 · Cited by 1,827
Cited by
Items 301–400 of 1,001
Ott, C. V., Macoveanu, J., Bowie, C. R., Fisher, P. M., Knudsen, G. M., Kessing, L. V., & Miskowiak, K. W. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00901-7 · Cited by 48
de Cates, A. N., Wright, L. C., Martens, M., Gibson, D., Türkmen, C., Filippini, N., Cowen, P. J., Harmer, C. J., & Murphy, S. E. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01568-4 · Cited by 48
Ranganathan, M., DeMartinis, N. A., Huguenel, B. M., Gaudreault, F., Bednar, M. M., Shaffer, C. L., Gupta, S., Cahill, J. D., Sherif, M. A., Mancuso, J. Y., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.6 · Cited by 48
Cognition in vestibular disorders: state of the field, challenges, and priorities for the future
Smith, L., Wilkinson, D. T., Bodani, M., & Surenthiran, S. S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1159174 · Cited by 47
Disinhibition, an emerging pharmacology of learning and memory
Möhler, H., & Rudolph, U. (2017) · F1000Research · doi:10.12688/f1000research.9947.1 · Cited by 47
Shen, J., Wang, C., Ying, J., Xu, T., McAlinden, A., & O’Keefe, R. J. (2019) · JCI Insight · doi:10.1172/jci.insight.128568 · Cited by 47
Ros‐Simó, C., Moscoso‐Castro, M., Ruiz‐Medina, J., Ros, J., & Valverde, O. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12247 · Cited by 46
Del’Guidice, T., Lemay, F., Lemasson, M., Levasseur‐Moreau, J., Manta, S., Etiévant, A., Escoffier, G., Doré, F. Y., Roman, F. S., & Beaulieu, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.313 · Cited by 46
Purkinje Cell-Specific Knockout of Tyrosine Hydroxylase Impairs Cognitive Behaviors
Locke, T. M., Fujita, H., Hunker, A. C., Johanson, S., Darvas, M., du Lac, S., Zweifel, L. S., & Carlson, E. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00228 · Cited by 46
“Is It Removed During Dialysis?”—Cognitive Dysfunction in Advanced Kidney Failure—A Review Article
Crowe, K., Quinn, T. J., Mark, P. B., & Findlay, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.787370 · Cited by 46
Salles, M., Hervé, D., Rivet, J., Longueville, S., Millan, M. J., Girault, J., & la Cour, C. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12206 · Cited by 46
Self-citationMillan, M. J., Rivet, J.-M., & Gobert, A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116672342 · Cited by 45
Self-citationXu, H., Zhang, Y., Zhang, F., Yuan, S., Shao, F., & Wang, W. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00095 · Cited by 45
Grennan, G., Withers, M. C., Ramanathan, D., & Mishra, J. (2023) · PLOS Climate · doi:10.1371/journal.pclm.0000125 · Cited by 45
Zhang, Y., Huang, C., Zhao, J., Liu, Y., Xia, M., Wang, X., Wei, D., Chen, Y., Liu, B., Zheng, Y., et al. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00323-0 · Cited by 44
Botellero, V. L., Skranes, J. S., Bjuland, K. J., Haberg, A. K., Lydersen, S., Brubakk, A., Indredavik, M. S., & Martinussen, M. (2017) · BMC Pediatrics · doi:10.1186/s12887-017-0793-0 · Cited by 44
Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First Episode
Zanelli, J., Reichenberg, A., Sandin, S., Morgan, C., Dazzan, P., Pilecka, I., Marques, T. R., Morgan, K. D., Young, A. H., & Mollon, J. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab150 · Cited by 44
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia
Moos, W. H., Maneta, E., Pinkert, C. A., Irwin, M. H., Hoffman, M. E., Faller, D. V., & Steliou, K. (2016) · Drug Development Research · doi:10.1002/ddr.21295 · Cited by 44
Zhou, L., Ma, S. L., Yeung, P. K. K., Wong, Y. H., Tsim, K. W. K., So, K., LAM, L. C. W., & Chung, S. K. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.129 · Cited by 44
HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice
Revenga, M. D. L. F., Ibi, D., Saunders, J. M., Cuddy, T., Ijaz, M. K., Toneatti, R., Kurita, M., Holloway, T. D., Shen, L., Seto, J., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.010 · Cited by 44
Bernard, R., Sabariego, C., & Cieza, A. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.5442 · Cited by 43
The effects of context processing on social cognition impairments in adults with Asperger's syndrome
Baez, S., & Ibanez, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00270 · Cited by 43
Arketamine for cognitive impairment in psychiatric disorders
Hashimoto, K. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01570-5 · Cited by 43
Chopra, S., Dhamala, E., Lawhead, C., Ricard, J. A., Orchard, E. R., An, L., Chen, P., Wulan, N., Kumar, P., Rubenstein, A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn1862 · Cited by 43
Neurocognitive functioning in patients with conversion disorder/functional neurological disorder
de Vroege, L., Koppenol, I., Kop, W. J., Riem, M. M. E., & Feltz-Cornelis, C. M. V. D. (2020) · Journal of Neuropsychology · doi:10.1111/jnp.12206 · Cited by 43
Revised Reading the Mind in the Eyes Test (RMET) - Brazilian version
Sanvicente‐Vieira, B., Kluwe‐Schiavon, B., Wearick‐Silva, L. E., Piccoli, G. L., Scherer, L. C., Tonelli, H. A., & Grassi‐Oliveira, R. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1162 · Cited by 43
Darcet, F., Gardier, A. M., David, D. J. P., & Guilloux, J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.055 · Cited by 43
Subjective Cognitive Symptoms During a Migraine Attack: A Prospective Study of a Clinic-Based Sample
Gil‐Gouveia, R., Oliveira, A. G., & Martins, I. P. (2016) · Pain Physician · doi:10.36076/ppj/2016.19.e137 · Cited by 43
Wolf, D., Klasen, M., Eisner, P. D., Zepf, F. D., Zvyagintsev, M., Palomero‐Gallagher, N., Weber, R., Eisert, A., & Mathiak, K. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1693-2 · Cited by 43
Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery
McArthur, R. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.004 · Cited by 42
Fu, X., Qin, T., Yu, J., Jiao, J., Ma, Z., Fu, Q., Deng, X., & Ma, S. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666190807160137 · Cited by 42
Sun, Y., Su, Y., Wang, Q., Zheng, J.-Y., Zhang, C., Wang, T., Liu, X., Ma, Y., Li, X., Zhang, X., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02476-5 · Cited by 42
Teng, L.-L., Lu, G., Chiou, L., Lin, W., Cheng, Y., Hsueh, T.-E., Huang, Y.-C., Hwang, N.-H., Yeh, J.-W., Liao, R., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2007097 · Cited by 42
Grychowska, K., Chaumont‐Dubel, S., Kurczab, R., Koczurkiewicz, P., Deville, C., Krawczyk, M., Pietruś, W., Satała, G., Buda, S., Piska, K., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00618 · Cited by 42
van Os, J., Pries, L.-K., ten Have, M., de Graaf, R., van Dorsselaer, S., Delespaul, P., Bak, M., Kenis, G., Lin, B. D., Luykx, J. J., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720003748 · Cited by 42
Prajapati, S. K., & Krishnamurthy, S. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113015 · Cited by 42
Zhu, J., Li, Y., Fang, Q., Shen, Y., Qian, Y., Cai, H., & Yu, Y. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102593 · Cited by 42
Gärtner, M., Ghisu, M. E., Scheidegger, M., Bönke, L., Fan, Y., Stippl, A., Herrera-Melendez, A.-L., Metz, S., Winnebeck, E., Fissler, M., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0081-1 · Cited by 41
“Since impairments at the cognition–emotion interface rather than of cognitive functions per se may be most characteristic for MDD [1], it seems particularly worthwhile to investigate cognition–emotion interactions in the brain in order to broaden our understanding of WM deficits in MDD.”
BackgroundNogueira, J., Gerardo, B., Silva, A. R., Pinto, P., Barbosa, R., Soares, S., Baptista, B., Paquete, C., Cabral-Pinto, M., Vilar, M. M., et al. (2022) · Current Psychology · doi:10.1007/s12144-021-01747-y · Cited by 41
Dercon, Q., Mehrhof, S. Z., Sandhu, T., Hitchcock, C., Lawson, R. P., Pizzagalli, D. A., Dalgleish, T., & Nord, C. L. (2023) · Psychological Medicine · doi:10.1017/s0033291723001587 · Cited by 41
Towards a Smart Population: A Public Health Framework for Cognitive Enhancement
Lucke, J. C., & Partridge, B. (2012) · Neuroethics · doi:10.1007/s12152-012-9167-3 · Cited by 41
Miskowiak, K. W., Schandorff, J. M., Jahn, F. S., & Kjærstad, H. L. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.044 · Cited by 41
Hatton, S. N., Lagopoulos, J., Hermens, D. F., Scott, E. M., Hickie, I. B., & Bennett, M. R. (2013) · International Journal of Bipolar Disorders · doi:10.1186/2194-7511-1-3 · Cited by 41
Reinwald, J., Becker, R., Mallien, A. S., Falfán-Melgoza, C., Sack, M., von Hohenberg, C. C., Braun, U., Cosa‐Linan, A., Gass, N., Vasilescu, A.-N., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.12.010 · Cited by 41
Self-citationObesity and Bipolar Disorder: Synergistic Neurotoxic Effects?
Liu, C. S., Carvalho, A. F., Mansur, R. B., & McIntyre, R. S. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0067-7 · Cited by 40
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease
Wyrofsky, R. R., McGonigle, P., & Bockstaele, E. J. V. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.966680 · Cited by 40
5-HT7 receptor activation: procognitive and antiamnesic effects
Meneses, A., Perez-Garcia, G., Liy-Salmerón, G., Ponce-López, T., Lacivita, E., & Leopoldo, M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3693-0 · Cited by 40
Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target
Calabrese, F., Riva, M. A., & Molteni, R. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1188080 · Cited by 38
Mahmood, Z., Burton, C. Z., Vella, L., & Twamley, E. W. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.011 · Cited by 40
Toader, O., von Heimendahl, M., Schuelert, N., Nissen, W., & Rosenbrock, H. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz123 · Cited by 40
Millan, M. J., Dekeyne, A., Gobert, A., Brocco, M., la Cour, C. M., Ortuno, J., Watson, D. J., & Fone, K. C. F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108099 · Cited by 40
Self-citationA Novel Virtual Reality Assessment of Functional Cognition: Validation Study
Porffy, L., Mehta, M. A., Patchitt, J., Boussebaa, C., Brett, J., D’Oliveira, T. C., Mouchlianitis, E. D., & Shergill, S. S. (2021) · Journal of Medical Internet Research · doi:10.2196/27641 · Cited by 40
Air, T., Weightman, M. J., & Baune, B. T. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01118 · Cited by 40
5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia
Meneses, A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00207 · Cited by 40
Social defeat-induced anhedonia: effects on operant sucrose-seeking behavior
Riga, D., Theijs, J. T., De Vries, T. J., Smit, A. B., & Spijker, S. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00195 · Cited by 39
Wang, X., Cheng, W., Zhu, J., Yin, H., Chang, S., Yue, W., & Yu, H. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.116 · Cited by 39
Mapping cognitive brain functions at scale
Balasubramani, P. P., Ojeda, A., Grennan, G., Maric, V., Le, H., Alim, F., Zafar-Khan, M., Diaz-Delgado, J., Silveira, S., Ramanathan, D., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2020.117641 · Cited by 39
Mannarelli, D., Pauletti, C., Missori, P., Trompetto, C., Cotellessa, F., Fattapposta, F., & Currà, A. (2023) · Brain Sciences · doi:10.3390/brainsci13121683 · Cited by 39
Waltereit, R., Banaschewski, T., Meyer‐Lindenberg, A., & Poustka, L. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.838641 · Cited by 39
Self-citationSargent, K., Chavez‐Baldini, U., Master, S. L., Verweij, K. J. H., Lok, A., Sutterland, A. L., Vulink, N. C. C., Denys, D. A. J. P., Smit, D. J. A., & Nieman, D. H. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102617 · Cited by 39
Psilocybin’s effects on cognition and creativity: A scoping review
Bonnieux, J. N., VanderZwaag, B., Premji, Z., Garcia‐Romeu, A., & García-Barrera, M. A. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231179801 · Cited by 39
Platt, J., McLaughlin, K. A., Luedtke, A. R., Ahern, J., Kaufman, A. S., & Keyes, K. M. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy006 · Cited by 39
Fiorillo, A., Carpiniello, B., Giorgi, S. D., Pia, S. L., Maina, G., Sampogna, G., Spina, E., Tortorella, A. A. V., & Vita, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00493 · Cited by 39
Lett, T. A. P., Vogel, B. O., Ripke, S., Wackerhagen, C., Erk, S., Awasthi, S., Trubetskoy, V., Brandl, E. J., Mohnke, S., Veer, I. M., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz270 · Cited by 39
Self-citationGrimm, C., Aksamaz, S., Schulz, S., Teutsch, J., Siciński, P., Liss, B., & Kätzel, D. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0268-6 · Cited by 38
Tzanoulinou, S., García-Mompó, C., Riccio, O., Grosse, J., Zanoletti, O., Dedousis, P., Nácher, J., & Sandi, C. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.200 · Cited by 38
Neuropsychological impairments in panic disorder: A systematic review
O׳Sullivan, K., & Newman, E. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.024 · Cited by 38
Duvarci, S., Simpson, E. H., Schneider, G., Kandel, E. R., Roeper, J., & Sigurdsson, T. (2018) · Nature Communications · doi:10.1038/s41467-018-05214-4 · Cited by 38
Nour, M. M., Dahoun, T., McCutcheon, R. A., Adams, R. A., Wall, M. B., & Howes, O. D. (2019) · eLife · doi:10.7554/elife.45045 · Cited by 38
Klanker, M., Sandberg, T., Joosten, R., Willuhn, I., Feenstra, M., & Denys, D. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.08.011 · Cited by 37
“…obsessive–compulsive disorder (OCD), drug addiction and Parkinson’s disease (Ceaser et al., 2008; Chamberlain, Fineberg, Blackwell, Robbins, & Sahakian, 2006; Cools, Barker, Sahakian, & Robbins, 2001; Millan et al., 2012; Verdejo-Garcia, Bechara, Recknor, & Perez-Garcia, 2006; Yerys et al., 2009).”
De Bundel, D., Femenía, T., DuPont, C. M., Konradsson-Geuken, Å., Feltmann, K., Schilström, B., & Lindskog, M. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000370 · Cited by 37
Dopamine D 3 Receptor Availability Is Associated with Inflexible Decision Making
Groman, S. M., Smith, N. J., Petrullli, J. R., Massi, B., Chen, L., Ropchan, J., Huang, Y., Lee, D., Morris, E. D., & Taylor, J. R. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3253-15.2016 · Cited by 37
The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy
Stone, T. W., Darlington, L. G., Badawy, A. A. ‐., & Williams, R. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169040 · Cited by 37
Trent, S., Abdullah, M. H., Parwana, K., Valdivieso, M. A., Hassan, Z., & Müller, C. P. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111310 · Cited by 37
Liu, G., Jiao, K., Zhong, Y., Hao, Z., Wang, C., Xu, H., Teng, C., Song, X., Xiao, C., Fox, P. T., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113018 · Cited by 37
Tyburski, E. M., Mak, M., Sokołowski, A., Starkowska, A., Karabanowicz, E., Kerestey, M., Lebiecka, Z., Preś, J., Sagan, L. M., Samochowiec, J., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132782 · Cited by 37
Lavigne, K. M., Deng, J., Raucher‐Chéné, D., Hotte‐Meunier, A., Voyer, C., Sarraf, L., Lepage, M., & Sauvé, G. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110894 · Cited by 36
Cuijpers, P. J., Harrer, M., & Furukawa, T. A. (2026) · World Psychiatry · doi:10.1002/wps.70002 · Cited by 36
Moscoso‐Castro, M., López‐Cano, M., Gracia‐Rubio, I., Ciruela, F., & Valverde, O. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.027 · Cited by 36
Zhang, Y., Xu, H., Zhang, F., Shao, F., Ellenbroek, B. A., Wang, J., & Wang, W. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.010 · Cited by 36
Fehring, D. J., Illipparampil, R., Acevedo, N., Jaberzadeh, S., Fitzgerald, P. B., & Mansouri, F. A. (2019) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2019.05.011 · Cited by 36
Goh, J.-Y., O’Sullivan, S. E., Shortall, S. E., Zordan, N., Piccinini, A. M., Potter, H. G., Fone, K. C. F., & King, M. V. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.076 · Cited by 36
Using Long-acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia
Correll, C. U., & Lauriello, J. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.ms19053ah5c · Cited by 36
Rosa, M., Scassellati, C., & Cattaneo, A. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1156415 · Cited by 36
Integrating a virtual reality relaxation clinic within acute psychiatric services: A pilot study
Riches, S., Nicholson, S. L., Fialho, C., Little, J., Ahmed, L., McIntosh, H., Kaleva, I., Sandford, T., Cockburn, R., Odoi, C. M., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115477 · Cited by 36
Greek, R., & Hansen, L. A. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.06.002 · Cited by 36
Wang, Z., Zhang, Y., Zhang, H., & Li, Y. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826115559 · Cited by 36
Xu, X., Zheng, C., An, L., Wang, R., & Zhang, T. (2016) · Brain Topography · doi:10.1007/s10548-016-0485-3 · Cited by 36
Lee, R. S. C., Hermens, D. F., Naismith, S. L., Kaur, M., Guastella, A. J., Glozier, N., Scott, J. L., Scott, E. M., & Hickie, I. B. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022659 · Cited by 36
Findling, R. L., & Dinh, S. M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0141-y · Cited by 36
The validation of a new online cognitive assessment tool: The MyCognition Quotient
Domen, A. C., van de Weijer, S. C. F., Jaspers, M., Denys, D. A. J. P., & Nieman, D. H. (2019) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1775 · Cited by 35
d -serine and schizophrenia: an update
Nunes, E. A., MacKenzie, E. M., Rossolatos, D., Perez-Parada, J., Baker, G. B., & Dursun, S. M. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.65 · Cited by 35
Effects of anterior cingulate cortex lesions on a continuous performance task for mice
Hvoslef‐Eide, M., Nilsson, S. R. O., Hailwood, J. M., Robbins, T. W., Saksida, L. M., Mar, A. C., & Bussey, T. J. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818772962 · Cited by 35
Xu, C., Niu, J., Zhou, J.-F., & Wei, Y. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.001 · Cited by 35
Rose, E. J., Picci, G., & Fishbein, D. H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00399 · Cited by 35
Cannon, C. E., Puri, V., Vivian, J. A., Egbertson, M. S., Eddins, D. M., & Uslaner, J. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.003 · Cited by 34
Riga, D., Schmitz, L. J. M., van der Harst, J. E., van Mourik, Y., Hoogendijk, W. J. G., Smit, A. B., Vries, T. J. D., & Spijker, S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.311 · Cited by 34
Engel, M., Snikeris, P., Jenner, A. M., Karl, T., Huang, X., & Frank, E. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu114 · Cited by 34
The effect of ketamine on the consolidation and extinction of contextual fear memory
Clifton, N. E., Thomas, K. L., & Hall, J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117748903 · Cited by 34
Morgan, J., Singhal, G., Corrigan, F., Jaehne, E. J., Jawahar, M. C., Breen, J., Pederson, S., & Baune, B. T. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.02.014 · Cited by 34
Metadata
- Authors
- Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., Dubois, B., Geyer, M. A., Goodwin, G. M., Gorwood, P., Jay, T. M., Joëls, M., Mansuy, I. M., Meyer-Lindenberg, A., Murphy, D., Rolls, E., Saletu, B., Spedding, M., Sweeney, J., Whittington, M., & Young, L. J.
- Affiliations
- Institut de Recherches Internationales Servier (France) (FR)
- Pitié-Salpêtrière Hospital (FR)
- University Hospitals of the Ruhr-University of Bochum (DE)
- University of Cambridge (GB)
- University of California, Davis (US)
- University of Massachusetts Dartmouth (US)
- Université Paris-Sud (FR)
- University of Pennsylvania (US)
- Institut du Cerveau (FR)
- University of California San Diego (US)
- Warneford Hospital (GB)
- Inserm (FR)
- University Medical Center Utrecht (NL)
- University of Zurich (CH)
- King's College London (GB)
- University of Warwick (GB)
- Medical University of Vienna (AT)
- Servier (France) (FR)
- The University of Texas Southwestern Medical Center (US)
- Newcastle University (GB)
- Emory University (US)
- Corresponding author
- Millan, Mark J.
- ORCID
- Millan, Mark J.
- Brüne, Martin
- Bullmore, Edward T.
- Carter, Cameron S.
- Clayton, Nicola S.
- Connor, Richard
- Davis, Sabrina
- DeRubeis, Robert J.
- Dubois, Bruno
- Geyer, Mark A.
- Goodwin, Guy M.
- Gorwood, Philip
- Jay, Thérèse M.
- Joëls, Marian
- Mansuy, Isabelle M.
- Murphy, Declan
- Rolls, Edmund
- Spedding, Michael
- Sweeney, John
- Whittington, Miles
- Young, Larry J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-02
- Volume
- 11
- Issue
- 2
- Pages
- 141-168
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2080092700
- Cited by
- 1,292
- References
- 274
- Citations by year
- 2026: 80 · 2025: 110 · 2024: 107 · 2023: 104 · 2022: 105 · 2021: 97 · 2020: 96 · 2019: 97 · 2018: 86 · 2017: 74 · 2016: 87 · 2015: 75 · 2014: 63 · 2013: 78 · 2012: 30
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (RP-PG-0606-1045, NF-SI-0509-10229)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- cognitive impairment, mental illness, depression, anxiety, hallucinations, translational research, animal models, cognitive function, quality of life, social and professional integration, cognitive therapy
- MeSH terms
- Mental Disorders, Brain, Cognition, Cognition Disorders, Humans, Magnetic Resonance Imaging, Neuropsychological Tests, Psychomotor Performance, Risk Factors, Stress, Psychological, Nootropic Agents, Genetic Predisposition to Disease, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.